Secondary prevention after myocardial infarction: a review of long-term trials.

[1]  Canner Pl.  Aspirin in coronary heart disease. Comparison of six clinical trials. , 1983 .

[2]  J. Kjekshus,et al.  Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial Infarction , 1982, Circulation.

[3]  D. DeMets,et al.  The randomized clinical trial: bias in analysis. , 1981, Circulation.

[4]  J. Mitchell.  ANTICOAGULANTS IN CORONARY HEART DISEASE—RETROSPECT AND PROSPECT , 1981, The Lancet.

[5]  R. Campbell,et al.  ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.

[6]  G. Pledger,et al.  The FDA's critique of the anturane reinfarction trial. , 1980, The New England journal of medicine.

[7]  J. Stamler.  Aspirin in coronary heart disease , 1980 .

[8]  L. Rydén,et al.  Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction. , 1980, American heart journal.

[9]  P. Macfarlane,et al.  A prospective randomized trial of tocainide in patients following myocardial infarction. , 1980, American heart journal.

[10]  A. M. Lefer,et al.  Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. , 1980, Circulation.

[11]  G. Rosenhamer,et al.  Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. , 1980, Atherosclerosis.

[12]  Lippincott Williams Wilkins,et al.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.

[13]  J. Lewis,et al.  Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. , 1980, British heart journal.

[14]  J. Hampton,et al.  Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. , 1980, British medical journal.

[15]  Jeremy N. Morris,et al.  W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. , 1980 .

[16]  P. Elwood,et al.  ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.

[17]  H. Hämäläinen,et al.  REDUCTION IN SUDDEN DEATHS BY A MULTIFACTORIAL INTERVENTION PROGRAMME AFTER ACUTE MYOCARDIAL INFARCTION , 1979, The Lancet.

[18]  F. Pedersen,et al.  EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Results , 1979, The Lancet.

[19]  W. O. Williams,et al.  A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction. , 1979, The Journal of the Royal College of General Practitioners.

[20]  L. Kuller,et al.  Hazards in the evaluation of secondary prevention trials. , 1979, American journal of epidemiology.

[21]  K Uberla,et al.  Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo , 1979, Thrombosis and Haemostasis.

[22]  L Goldman,et al.  Anticoagulants and myocardial infarction. The problems of pooling, drowning, and floating. , 1979, Annals of internal medicine.

[23]  T. Peter,et al.  Effect on survival after myocardial infarction of long-term treatment with phenytoin. , 1978, British heart journal.

[24]  S. Moncada,et al.  ASPIRIN: A PARADOXICAL EFFECT ON BLEEDING-TIME , 1978, The Lancet.

[25]  T C Chalmers,et al.  Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. , 1977, The New England journal of medicine.

[26]  G. Rosenhamer,et al.  Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. , 1977, Atherosclerosis.

[27]  C. Penington,et al.  Changing patterns and mortality of acute myocardial infarction in a coronary care unit. , 1977, British medical journal.

[28]  I. Cooke,et al.  Problems in using basal body temperature recordings in an infertility clinic. , 1977, British medical journal.

[29]  M. Walsh,et al.  Practolol in acute myocardial infarction. , 2009, Acta medica Scandinavica. Supplementum.

[30]  J. Seibert,et al.  PARENTAL CONSANGUINITY IN PYCNODYSOSTOSIS , 1976, The Lancet.

[31]  I. Palatsi.  Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality. , 1976, Acta medica Scandinavica. Supplementum.

[32]  L. Wilhelmsen,et al.  A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death. , 1975, Preventive medicine.

[33]  H. Keen,et al.  ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.

[34]  M. S. Yuhasz,et al.  A controlled prospective study of the effect of endurance training on the recurrence rate of myocardial infarction. A description of the experimental design. , 1975, American Journal of Epidemiology.

[35]  S. P. Allison,et al.  ELEMENTAL DIETS , 1975, The Lancet.

[36]  I. Strøyer,et al.  C1-ESTERASE INACTIVATORS AND C4 IN MALIGNANT DISEASES , 1975, The Lancet.

[37]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[38]  G. Ahlmark,et al.  REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION , 1974 .

[39]  Parker Je.  Letter: Postoperative immunosuppression. , 1974 .

[40]  L. Wilhelmsen,et al.  Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. , 1974, Lancet.

[41]  K. Detre,et al.  Long‐term Changes of Serum Cholesterol with Cholesterol‐altering Drugs in Patients with Coronary Heart Disease: Veterans Administration Drug‐Lipid Cooperative Study , 1974, Circulation.

[42]  E. Lloyd.  EXERCISE AND MYOCARDIAL INFARCTION , 1974 .

[43]  P C Elwood,et al.  A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.

[44]  R. White,et al.  Pulmonary Function after Lymphography , 1973 .

[45]  D. Kaiser,et al.  Letter: Cystic-fibrosis factor and metachromasia of cultured cystic-fibrosis fibroblast. , 1973, Lancet.

[46]  C. Ruckley,et al.  Prevention of pulmonary embolism. , 1973, British medical journal.

[47]  H. Sanne.  Exercise tolerance and physical training of non-selected patients after myocardial infarction. , 1973, Acta medica Scandinavica. Supplementum.

[48]  L. T. Sheffield,et al.  Natural history of coronary artery disease. , 1972, Bulletin of the New York Academy of Medicine.

[49]  J. Stamler.  The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. , 1972, JAMA.

[50]  E. Kentala.  Physical fitness and feasibility of physical rehabilitation after myocardial infarction in men of working age. , 1972, Annals of clinical research.

[51]  P. Leren.  The Oslo Diet‐Heart Study: Eleven‐Year Report , 1970, Circulation.

[52]  H. Griswold,et al.  Long-term anticoagulant prophylaxis after myocardial infarction. , 1969, The New England journal of medicine.

[53]  P. Leren.  The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. , 1968, Bulletin of the New York Academy of Medicine.

[54]  C. W. Frank,et al.  Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. , 1968, American journal of public health and the nation's health.

[55]  M. Rosen,et al.  Concentration of methoxyflurane for obstetric analgesia by self-administered intermittent inhalation. , 1967, British medical journal.

[56]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[57]  W. Belton.  Consultants' views of general practitioners , 1967 .

[58]  J. A. Brown,et al.  Glomerular Filtration Rate , 1967 .

[59]  Stathers Gm.  PORPHYRIN-BINDING EFFECT OF CHOLESTYRAMINE , 1966 .

[60]  L. Gutterman,et al.  Anticoagulants in acute myocardial infarction. The failure of anticoagulants to alter mortality in a randomized series. , 1966, American heart journal.

[61]  E. Rice-wray.  AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL. , 1964, British medical journal.

[62]  S. Pell,et al.  IMMEDIATE MORTALITY AND FIVE-YEAR SURVIVAL OF EMPLOYED MEN WITH A FIRST MYOCARDIAL INFARCTION. , 1964, The New England journal of medicine.

[63]  J. Stamler,et al.  Effectiveness of estrogens for therapy of myocardial infarction in middle-age men. , 1963, JAMA.

[64]  Jerome Cornfield,et al.  A Statistical Problem Arising from Retrospective Studies , 1956 .

[65]  J. Crooks,et al.  L. Canicola Infection Treated by Penicillin , 1955, British medical journal.

[66]  Craven Ll.  Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. , 1953 .

[67]  J. Cornfield,et al.  A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. , 1951, Journal of the National Cancer Institute.

[68]  J. Herrick.  CLINICAL FEATURES OF SUDDEN OBSTRUCTION OF THE CORONARY ARTERIES , 1912 .